Page last updated: 2024-11-07

cerebronic acid

Description Research Excerpts Clinical Trials Roles Classes Pathways Study Profile Bioassays Related Drugs Related Conditions Protein Interactions Research Growth Market Indicators

Description

Cerebronic acid, also known as 2-hydroxytetracosanoic acid, is a long-chain fatty acid found in the brain and other tissues. It is a component of sphingolipids, which are important for cell signaling and membrane structure. Cerebronic acid is synthesized from palmitic acid and stearic acid through a series of enzymatic reactions. Its biosynthesis involves the elongation of palmitate to form the 24-carbon chain. It has been studied for its potential role in various neurological disorders, including Alzheimer's disease and multiple sclerosis. The accumulation of cerebronic acid in the brain has been linked to the formation of plaques, which are characteristic of Alzheimer's disease. Its role in multiple sclerosis is related to its presence in myelin, the protective sheath around nerve fibers. Studies on cerebronic acid aim to understand its role in brain function and its potential as a therapeutic target in neurological disorders.'

cerebronic acid : A very long-chain hydroxy fatty acid composed of lignoceric acid having a 2-hydroxy substituent. [Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Cross-References

ID SourceID
PubMed CID102430
CHEBI ID61302
SCHEMBL ID338278
MeSH IDM0045224

Synonyms (29)

Synonym
544-57-0
dl-cerebronic acid
phrenosinic acid
2-hydroxy-tetracosanoic acid
LMFA01050080
phrenosic acid
2-hydroxytetracosanoic acid
cerebronic acid
CHEBI:61302
2-hydroxytetraicosanoic acid
2-hydroxytetraeicosanoic acid
cerebronsaeure
2-hydroxylignoceric acid
acide cerebronique
2-hydroxy-tetracosansaeure
C17873
unii-66qn3b074e
66qn3b074e ,
FT-0632358
SCHEMBL338278
.alpha.-hydroxytetracosanoic acid
tetracosanoic acid, 2-hydroxy-
.alpha.-hydroxylignoceric acid
AKOS027379899
2-hydroxy lignoceric acid
a-hydroxylignoceric acid
Q11751627
DTXSID40969526
PD060508
[information is derived through text-mining from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Drug Classes (3)

ClassDescription
straight-chain fatty acidAny fatty acid whose skeletal carbon atoms form an unbranched open chain.
2-hydroxy fatty acidAny fatty acid with a hydroxy functional group in the alpha- or 2-position.
very long-chain fatty acidA fatty acid which has a chain length greater than C22. Very long-chain fatty acids which have a chain length greater than C27 are also known as ultra-long-chain fatty acids.
[compound class information is derived from Chemical Entities of Biological Interest (ChEBI), Hastings J, Owen G, Dekker A, Ennis M, Kale N, Muthukrishnan V, Turner S, Swainston N, Mendes P, Steinbeck C. (2016). ChEBI in 2016: Improved services and an expanding collection of metabolites. Nucleic Acids Res]

Research

Studies (5)

TimeframeStudies, This Drug (%)All Drugs %
pre-19903 (60.00)18.7374
1990's0 (0.00)18.2507
2000's2 (40.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]

Market Indicators

Research Demand Index: 50.97

According to the monthly volume, diversity, and competition of internet searches for this compound, as well the volume and growth of publications, there is estimated to be very strong demand-to-supply ratio for research on this compound.

MetricThis Compound (vs All)
Research Demand Index50.97 (24.57)
Research Supply Index1.79 (2.92)
Research Growth Index4.21 (4.65)
Search Engine Demand Index73.70 (26.88)
Search Engine Supply Index2.00 (0.95)

This Compound (50.97)

All Compounds (24.57)

Study Types

Publication TypeThis drug (%)All Drugs (%)
Trials0 (0.00%)5.53%
Reviews0 (0.00%)6.00%
Case Studies0 (0.00%)4.05%
Observational0 (0.00%)0.25%
Other5 (100.00%)84.16%
[information is prepared from research data collected from National Library of Medicine (NLM), extracted Dec-2023]